Opaleye Management Inc.'s Form 4 filing
Eton Pharmaceuticals, Inc. (ETON) · filed Oct 8, 2024
- Accession no.
- 0001493152-24-040490
- Filed
- Oct 8, 2024
- Trade date
- Oct 4-8, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market purchases total $434.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Opaleye Management Inc.CIK 0001595855 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 4, 2024 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +15,000 | $6.77 | +$101,550 | 2,720,000 | Indirect | |
| Oct 4, 2024 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +1,852 | $6.77 | +$12,538.04 | 76,852 | Indirect | |
| Oct 7, 2024 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +10,000 | $7.22 | +$72,200 | 2,730,000 | Indirect | |
| Oct 7, 2024 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +1,248 | $7.22 | +$9,010.56 | 78,100 | Indirect | |
| Oct 8, 2024 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +30,000 | $7.03 | +$210,900 | 2,760,000 | Indirect | |
| Oct 8, 2024 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +3,970 | $7.03 | +$27,909.1 | 82,070 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.